Top Abstract Purchase Related
Home
>
Node
>
Subnode

Cyclic adenosine monophosphate antagonism of prostaglandin induced vasospasm

Peterson, E.W.; Leblanc, R.; Lebel, F.

Surgical Neurology 4(6): 490-496

1975

ISSN/ISBN: 0090-3019
PMID: 171784
Document Number: 94197
Prostaglandin F2alpha was applied topically to the transclivally exposed basilar artery of the cat. The resultant vasoconstriction and its reversal by dibutyryl cyclic adenosine monophosphate was recorded photographically and measured, and the results analyzed statistically. Arterial BP, pCO2' pO2 and pH were determined to insure that the vascular responses were not due to any general physiological disturbance. The results indicated that Prostaglandin F2alpha is a powerful vasoconstrictive substance and that its effects are readily reversible by dibutyryl cyclic adenosine monophosphate.

Document emailed within 1 workday
Secure & encrypted payments

Williams, J.G.; Garcia, I.; Maier, R.V. 1993: Prostaglandin E2 mediates lipopolysaccharide-induced macrophage procoagulant activity by a cyclic adenosine monophosphate-dependent pathway Surgery 114(2): 314-323
Polson, J.B.; Krzanowski, J.J.; Szentivanyi, A. 1974: Histamine induced changes in pulmonary guanosine-3',5'-cyclic monophosphate (cGMP) and adenosine-3',5'-cyclic monophosphate (cAMP) levels in mice following sensitization by Bordetella pertussis and/or propranolol Research Communications in Chemical Pathology and Pharmacology 9(2): 243-251
Gamelli, R.L.; He, L.K.; Liu, H.; Ricken, J.D. 1998: Burn wound infection-induced myeloid suppression: the role of prostaglandin E2, elevated adenylate cyclase, and cyclic adenosine monophosphate Journal of Trauma 44(3): 469-474
Goldring, S.R.; Amento, E.P.; Roelke, M.S.; Krane, S.M. 1986: The adenosine 3':5'-cyclic monophosphate response to prostaglandin E2 is altered in U937 cells in association with maturational events induced by activated T lymphocytes and 1,25-dihydroxyvitamin D3 Journal of Immunology 136(9): 3461-3466
Yamasaki, Y.; Fujiwara, M.; Toda, N. 1974: Effects of intracellularly applied cyclic 3',5'-adenosine monophosphate and dibutyryl cyclic 3',5'-adenosine monophosphate on the electrical activity of sinoatrial nodal cells of the rabbit Journal of Pharmacology and Experimental Therapeutics 190(1): 15-20
Nedvídková, J.; Felt, V. 1984: Plasma levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) in patients with thyropathies Casopis Lekaru Ceskych 123(27): 835-837
Babeş, L.; Gagheş, A.; Orăşanu, M.; Teletin, N.; Petraşincu, D.E.; Codău, M. 1992: Effect of prostaglandin E2 (PGE2) and cyclic adenosine monophosphate (cAMP) upon actin cytoskeleton in human pulmonary fibroblasts (ICP-23) infected by measles virus Roumanian Archives of Microbiology and Immunology 51(4): 239-251
McNeill, J.; Verma, S.C. 1973: Phenylephrine-induced increases in cardiac contractility, cyclic adenosine monophosphate and phosphorylase a Journal of Pharmacology and Experimental Therapeutics 187(2): 296-299
Minina, S.V. 1986: Variability of the response types induced by cyclic 3',5'-adenosine monophosphate into identified molluscan neurons Biofizika 31(5): 919-921
Nikulin, A.A. 1978: Effect of cyclic adenosine monophosphate and guanosine monophosphate on the aggregation and nucleotide metabolism of the blood platelets Farmakologiia i Toksikologiia 41(2): 177-182
Pepe, S.; Tortora, G.; Noguchi, P.D.; Marti, G.E.; Washington, G.C.; Cho-Chung, Y.S. 1991: Effects of 8-chloroadenosine 3',5'-monophosphate and N6-benzyl-cyclic adenosine 5'-monophosphate on cell cycle kinetics of HL-60 leukemia cells Cancer Research 51(23 Part 1): 6263-6267
Polson, J.B.; Goldberg, N.D.; Shideman, F.E. 1977: Norepinephrine- and isoproterenol- induced changes in cardiac contractility and cyclic adenosine 3':5' -monophosphate levels during early development of the embryonic chick Journal of Pharmacology and Experimental Therapeutics 200(3): 630-637
Hoffmann, M.K. 1988: The requirement for high intracellular cyclic adenosine monophosphate concentrations distinguishes two pathways of B cell activation induced with lymphokines and antibody to immunoglobulin Journal of Immunology 140(2): 580-582
Parfitt, A.; Weller, J.L.; Klein, D.C.; Sakai, K.K.; Marks, B.H. 1975: Blockade by ouabain or elevated potassium ion concentration of the adrenergic and adenosine cyclic 3',5'-monophosphate-induced stimulation of pineal serotonin N-acetyltransferase activity Molecular Pharmacology 11(3): 241-255
Bershteĭn, L.M.; Dil'man, V.M. 1974: Cyclic adenosine monophosphate and prostaglandins in oncology Voprosy Onkologii 20(3): 105-120
Keighley, G.; Cohen, N.S. 1978: Stimulation of erythropoiesis in mice by adenosine 3',5'-monophosphate and prostaglandin E1 Journal of Medicine 9(2): 129-138
Jain, S.K. 1978: Synthesis of a specific protein by adenosine 3',5'-cyclic monophosphate in rat uterus Indian Journal of Biochemistry and Biophysics 15(4): 345-347
Stefanovich, V. 1975: Inhibition of platelet cyclic 3',5'-adenosine-monophosphate phosphodiesterases by pentifylline Arzneimittel-Forschung 25(5): 740-741
Heikkinen, E.R. 1977: Distribution of exogenous cyclic adenosine 3', 5'-monophosphate in rabbits and cats Medical Biology 55(2): 82-87
Pawlikowski, M.; Lewandowski, J. 1973: Cyclic adenosine-3',5'-monophosphate as the intracellular mediator of hormonal action Endokrynologia Polska 24(2): 105-132